Recent Updates
Recently added Catalysts

Premetrexed

Phase 1

Inoperable Non Small Cell Lung Cancer | Small molecule | Oncology |Eli Lilly and Company|Trials Updated: May 2, 2025

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLEDDMC
Total Trials1
Total Enrollment18

FDA Designations

No designations recorded

Premetrexed clinical trials

Premetrexed · 1 trial · 1 indication

Phase 1 1
NCT00330044Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerInoperable Non Small Cell Lung Cancer
COMPLETED18 Analytics
PHASE1COMPLETED
Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer
Inoperable Non Small Cell Lung Cancer
NCT0033004418
Unlock trial analytics

Study Endpoints

Primary Endpoints

Response and Progression Free Survival
Up to five years after study completion
Unlock Study Endpoints

Study Design & Arms

AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
DrugEXPERIMENTALCarboplatin and Pemetrexed

Interventions

NameTypeDescription
Premetrexed (Alimta)DRUG -
CarboplatinDRUG -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Unresectable Stage II, IIIB or IV non small cell lung cancer. Evaluable disease on planning CT scan Zubrod 0-1 Weight loss equal to or less than 10% 3 months prior to diagnosis FEV1 greater than 1000cc Adequate hematologic, renal and hepatic functions Exclusion Criteria: * S...

Countries:United States
Unlock Eligibility Criteria

Explore more on BiopharmaWatch

Eli Lilly and Company (LLY)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with PCompanies A to ZEvery biotech and pharma company we track